ISCA1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.824000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.606600E-01
Normal-vs-Stage2
4.096400E-01
Normal-vs-Stage3
8.160300E-02
Normal-vs-Stage4
8.472800E-01
Stage1-vs-Stage2
4.641600E-02
Stage1-vs-Stage3
3.014300E-02
Stage1-vs-Stage4
4.776000E-01
Stage2-vs-Stage3
1.068080E-02
Stage2-vs-Stage4
4.944800E-01
Stage3-vs-Stage4
6.058400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.919400E-01
Normal-vs-AfricanAmerican
6.760400E-01
Normal-vs-Asian
5.384600E-01
Caucasian-vs-AfricanAmerican
9.915400E-01
Caucasian-vs-Asian
7.975800E-01
AfricanAmerican-vs-Asian
8.295800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.572200E-01
Normal-vs-Female
8.331000E-01
Male-vs-Female
2.019800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.630200E-01
Normal-vs-Age(41-60Yrs)
9.341200E-01
Normal-vs-Age(61-80Yrs)
4.850000E-01
Normal-vs-Age(81-100Yrs)
2.482200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.101600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.576800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.090800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.212000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.748000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.755000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.588000E-02
Normal-vs-Daily Drinker
6.722000E-01
Normal-vs-Weekly Drinker
5.202200E-01
Normal-vs-Occasional Drinker
8.945000E-01
Normal-vs-Social Drinker
8.308000E-01
Non Drinker-vs-Daily Drinker
1.566550E-01
Non Drinker-vs-Weekly Drinker
1.083050E-01
Non Drinker-vs-Occasional Drinker
7.292100E-02
Non Drinker-vs-Social Drinker
7.792100E-02
Daily Drinker-vs-Weekly Drinker
9.231600E-01
Daily Drinker-vs-Occasional Drinker
6.075000E-01
Daily Drinker-vs-Social Drinker
3.291800E-01
Weekly Drinker-vs-Occasional Drinker
5.497000E-01
Weekly Drinker-vs-Social Drinker
2.884800E-01
Occasional Drinker-vs-Social Drinker
5.325000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.044200E-01
Normal-vs-Grade 2
9.621800E-01
Normal-vs-Grade 3
9.570600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.193400E-01
Grade 1-vs-Grade 3
7.472400E-02
Grade 1-vs-Grade 4
7.044200E-01
Grade 2-vs-Grade 3
6.969500E-02
Grade 2-vs-Grade 4
9.621800E-01
Grade 3-vs-Grade 4
9.570600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.485600E-01
Normal-vs-NonDiabetic
7.750800E-01
Diabetic-vs-NonDiabetic
6.294100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.088600E-01
Normal-vs-NoPancreatitis
6.884000E-01
Pancreatitis-vs-NoPancreatitis
2.911400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.326400E-01
Normal-vs-N1
4.589200E-01
N0-vs-N1
2.477800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.877800E-01
Normal-vs-TP53-NonMutant
8.900000E-01
TP53-Mutant-vs-TP53-NonMutant
3.999400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
